» Articles » PMID: 8643488

Sensitivity and Selectivity of the DNA Damage Sensor Responsible for Activating P53-dependent G1 Arrest

Overview
Specialty Science
Date 1996 May 14
PMID 8643488
Citations 106
Authors
Affiliations
Soon will be listed here.
Abstract

The tumor suppressor p53 contributes to maintaining genome stability by inducing a cell cycle arrest or apoptosis in response to conditions that generate DNA damage. Nuclear injection of linearized plasmid DNA, circular DNA with a large gap, or single-stranded circular phagemid is sufficient to induce a p53-dependent arrest. Supercoiled and nicked plasmid DNA, and circular DNA with a small gap were ineffective. Titration experiments indicate that the arrest mechanism in normal human fibroblasts can be activated by very few double strand breaks, and only one may be sufficient. Polymerase chain reaction assays showed that end-joining activity is low in serum-arrested human fibroblasts, and that higher joining activity occurs as cells proceed through G1 or into S phase. We propose that the exquisite sensitivity of the p53-dependent G1 arrest is partly due to inefficient repair of certain types of DNA damage in early G1.

Citing Articles

DNA damage checkpoints balance a tradeoff between diploid- and polyploid-derived arrest failures.

Fujimaki K, Jambhekar A, Lahav G bioRxiv. 2025; .

PMID: 39990415 PMC: 11844538. DOI: 10.1101/2025.02.14.638318.


Stress Management in Plants: Examining Provisional and Unique Dose-Dependent Responses.

Georgieva M, Vassileva V Int J Mol Sci. 2023; 24(6).

PMID: 36982199 PMC: 10049000. DOI: 10.3390/ijms24065105.


Changes in calpain-2 expression during glioblastoma progression predisposes tumor cells to temozolomide resistance by minimizing DNA damage and p53-dependent apoptosis.

Stillger M, Chen C, Lai Z, Li M, Schafer A, Pagenstecher A Cancer Cell Int. 2023; 23(1):49.

PMID: 36932402 PMC: 10022304. DOI: 10.1186/s12935-023-02889-8.


Cancer and Radiosensitivity Syndromes: Is Impaired Nuclear ATM Kinase Activity the Primum Movens?.

El Nachef L, Berthel E, Ferlazzo M, Le Reun E, Al-Choboq J, Restier-Verlet J Cancers (Basel). 2022; 14(24).

PMID: 36551628 PMC: 9776478. DOI: 10.3390/cancers14246141.


CRISPR Activation/Interference Screen to Identify Genetic Networks in HDAC-Inhibitor-Resistant Cells.

Jung P, Schmalbrock L, Wirth M Methods Mol Biol. 2022; 2589:429-454.

PMID: 36255641 DOI: 10.1007/978-1-0716-2788-4_28.


References
1.
Tlsty T, Margolin B, Lum K . Differences in the rates of gene amplification in nontumorigenic and tumorigenic cell lines as measured by Luria-Delbrück fluctuation analysis. Proc Natl Acad Sci U S A. 1989; 86(23):9441-5. PMC: 298512. DOI: 10.1073/pnas.86.23.9441. View

2.
Hupp T, Sparks A, Lane D . Small peptides activate the latent sequence-specific DNA binding function of p53. Cell. 1995; 83(2):237-45. DOI: 10.1016/0092-8674(95)90165-5. View

3.
Tlsty T . Normal diploid human and rodent cells lack a detectable frequency of gene amplification. Proc Natl Acad Sci U S A. 1990; 87(8):3132-6. PMC: 53848. DOI: 10.1073/pnas.87.8.3132. View

4.
Mercer W, Shields M, Amin M, Sauve G, Appella E, Romano J . Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53. Proc Natl Acad Sci U S A. 1990; 87(16):6166-70. PMC: 54493. DOI: 10.1073/pnas.87.16.6166. View

5.
Greider C . Telomeres, telomerase and senescence. Bioessays. 1990; 12(8):363-9. DOI: 10.1002/bies.950120803. View